# Phase 4 Colitis, Ulcerative trials recruiting: 28 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 28 trials in phase 4 for Colitis, Ulcerative that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 4 Colitis, Ulcerative trials: 28 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-4/colitis-ulcerative

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 28
- Recruiting or not yet: 28
- Read on: November 19, 2026

## Trials

The 25 newest of 28, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 24, 2026 | NCT07782242 | Comaprison of Efficacy and Safety Between Etrasimod vs Mesalazine in Chinese Adults With Active UC | Sir Run Run Shaw Hospital | Phase 4 | Not yet recruiting | Etrasimod, Mesalazine, Ulcerative Colitis (UC), Head-to-head | 320 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07782242) |
| August 19, 2026 | NCT07773948 | ASAPP Study - Topical 5-ASA as Prophylaxis for Pouchitis in Ulcerative Colitis Patients After Pelvic Pouch Surgery | University Hospital, Linkoeping | Phase 4 | Not yet recruiting | Ulcerative Colitis (UC), Pouchitis | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07773948) |
| August 11, 2026 | NCT07758335 | The Efficacy of Lactobacillous Probiotic and Trace Elements in the Management of Ulcerative Colitis Patients the Patients Will be Recruited... | National Hepatology & Tropical Medicine Research Institute | Phase 4 | Recruiting | Ulcerative Colitis (UC) | 132 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07758335) |
| July 22, 2026 | NCT07718529 | Safety and Efficacy of a STOPping Strategy Versus Classical Maintenance Dose of JAK Inhibitors in Deep Remission Patients With Ulcerative... | Assistance Publique Hopitaux De Marseille | Phase 4 | Not yet recruiting | Ulcerative Colitis in Remission | 224 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07718529) |
| July 14, 2026 | NCT07700446 | Efficacy of Upadacitinib Re-induction Therapy in Patients With Ulcerative Colitis Who Lost Response to 30 mg Maintenance Dose | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | Phase 4 | Not yet recruiting | Ulcerative Colitis (UC) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07700446) |
| July 8, 2026 | NCT07691138 | Stopping PPI Therapy in Inactive IBD | University of Nottingham | Phase 4 | Recruiting | Ulcerative Colitis (UC), Crohn's Disease | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07691138) |
| June 24, 2026 | NCT07665294 | Combination CurQD and Vedolizumab in Ulcerative Colitis | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Ulcerative Colitis | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07665294) |
| June 17, 2026 | NCT07654751 | A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically | Janssen Research & Development, LLC | Phase 4 | Recruiting | Psoriasis, Colitis, Ulcerative, Crohn Disease, Arthritis, Psoriatic | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07654751) |
| May 8, 2026 | NCT07576452 | FirST Lines of Biologics in pAtients With ulceRaTivE Colitis: a Randomised Controlled Trial | University Hospital, Clermont-Ferrand | Phase 4 | Not yet recruiting | Ulcerative Colitis (UC) | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07576452) |
| March 31, 2026 | NCT07502339 | Upadacitinib in Patients Hospitalized With Acute Severe Ulcerative Colitis | University of California, San Francisco | Phase 4 | Not yet recruiting | UC - Ulcerative Colitis | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07502339) |
| December 26, 2025 | NCT07303686 | De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis | McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 4 | Recruiting | Crohn Disease (CD), Ulcerative Colitis (UC) | 115 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07303686) |
| November 25, 2025 | NCT07248644 | Immunosuppressant Discontinuation in Elderly Patients With Ulcerative Colitis And Long-term Remission | Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa | Phase 4 | Not yet recruiting | Ulcerative Colitis (UC) | 304 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07248644) |
| November 21, 2025 | NCT07240649 | Emerging Indications for Hyperbaric Oxygen Treatment | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Post-COVID-19 Condition, Ulcerative Colitis, Crohn Disease, Calciphylaxis, Frostbite, Acute COVID-19, Pyoderma... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07240649) |
| November 19, 2025 | NCT07235904 | Efficacy of Top-down Therapy With Mirikizumab Versus Standard of Care With Azathioprine in Patients With Newly Diagnosed Moderate-to-severe... | University Hospital Schleswig-Holstein | Phase 4 | Recruiting | Ulcerative Colitis (UC) | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07235904) |
| October 14, 2025 | NCT07216014 | Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety | Sixth Affiliated Hospital, Sun Yat-sen University | Phase 4 | Recruiting | Crohn's Disease and Ulcerative Colitis | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07216014) |
| July 10, 2025 | NCT07059130 | Evaluating the Efficacy and Safety of Mirikizumab in Adults Over 60 With Moderate to Severe Crohn's Disease and Ulcerative Colitis | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Crohn Disease (CD), Crohns Disease, Ulcerative Colitis (UC) | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07059130) |
| January 27, 2025 | NCT06794944 | Use of Fidaxomicin Compared to Vancomycin for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease | Brigham and Women's Hospital | Phase 4 | Not yet recruiting | Inflammatory Bowel Disease (IBD), Clostridioides Difficile Infection | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06794944) |
| September 24, 2024 | NCT06609447 | The Efficacy and Safety of Combining Probiotic VSL#3 With Vedolizumab for the Treatment of Moderate Ulcerative Colitis | Second Affiliated Hospital, Zhejiang University, School of Medicine | Phase 4 | Recruiting | Ulcerative Colitis | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06609447) |
| September 3, 2024 | NCT06581328 | A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting | Takeda | Phase 4 | Recruiting | Ulcerative Colitis, Crohn's Disease | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06581328) |
| March 7, 2024 | NCT06298461 | Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease. | University of Manitoba | Phase 4 | Recruiting | Crohn Disease, Ulcerative Colitis | 418 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06298461) |
| November 2, 2023 | NCT06113913 | Subcutaneous Infliximab After A Previous Intravenous Dose Optimization | Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW | Phase 4 | Recruiting | Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis | 275 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06113913) |
| August 4, 2023 | NCT05976802 | Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17... | Bausch Health Americas, Inc. | Phase 4 | Not yet recruiting | Ulcerative Colitis | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05976802) |
| August 1, 2022 | NCT05481619 | Study of the Effect of Vedolizumab on Intestinal Microecological Changes and Its Efficacy in the Treatment of Ulcerative Colitis | Second Affiliated Hospital, Zhejiang University, School of Medicine | Phase 4 | Recruiting | Ulcerative Colitis | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05481619) |
| August 10, 2021 | NCT04999241 | Combined Application of EEN in the Induction of Remission in PUC | Children's Hospital of Fudan University | Phase 4 | Not yet recruiting | Exclusive Enteral Nutrition, Ulcerative Colitis, Children | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04999241) |
| August 10, 2021 | NCT04999228 | Top Down Versus Step up in Pediatric Ulcerative Colitis | Children's Hospital of Fudan University | Phase 4 | Recruiting | Ulcerative Colitis, Infliximab, Children | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04999228) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Children's Hospital of Fudan University | 2 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
| [Bausch Health Americas, Inc.](https://specstream.ai/data/clinical-trials/company/bausch-health-americas-inc) | 2 |
| Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2 |
| Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW | 1 |
| University of California, San Francisco | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 1 |
| Brigham and Women's Hospital | 1 |
| University of Manitoba | 1 |
| Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa | 1 |
| University Hospital Schleswig-Holstein | 1 |
| Sir Run Run Shaw Hospital | 1 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| University Hospital, Linkoeping | 1 |
| University Hospital, Clermont-Ferrand | 1 |
| Sixth Affiliated Hospital, Sun Yat-sen University | 1 |
| University of Nottingham | 1 |
| National Hepatology & Tropical Medicine Research Institute | 1 |
| Centre Hospitalier Universitaire, Amiens | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 7 |
| China | 4 |
| France | 4 |
| Canada | 2 |
| Belgium | 1 |
| Germany | 1 |
| Sweden | 1 |
| Israel | 1 |
| United Kingdom | 1 |
| Egypt | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Dental laboratories in the United States](https://specstream.ai/data/businesses/dental-laboratories/united-states)
- [Syrian restaurants in the United States](https://specstream.ai/data/businesses/syrian-restaurants/united-states)
- [Hydraulic repair companies in the United States](https://specstream.ai/data/businesses/hydraulic-repair-companies/united-states)
- [B2B oil refinery companies in the United States](https://specstream.ai/data/businesses/b2b-oil-refinery-companies/united-states)
- [Pediatric oncology practices in the United States](https://specstream.ai/data/businesses/pediatric-oncology-practices/united-states)
- [Dumpster rental companies in the United States](https://specstream.ai/data/businesses/dumpster-rental-companies/united-states)
